Connecting the Dots: The Digest’s 2019 Multi-Slide Guide to Evogene

Evogene combines expertise in life science and cutting-edge computational technology to connect the dots in agriculture. They develop novel products for life science markets through the use of a unique computational predictive biology platform. In Agriculture, the Company currently focuses on three key target markets: Seeds – addressing essential seed traits such as: yield, environmental stresses and resistance to insects and diseases; Ag-Chemicals (AgPlenus) – developing novel herbicides and insecticides; Ag-Biologicals (Lavie Bio)– developing a broad range of bio-stimulants & bio-pesticides.

Evogene’s business model is composed of independent or collaborative R&D with advanced development and commercialization conducted by our partners. Evogene currently has strategic collaborations and licensing agreements with world-leading agricultural companies, such as: BASF, Corteva, ICL, Monsanto and more. Evogene has three subsidiaries focusing on agriculture, industry end-markets and pharma: 1) AgPlenus –  focusing on the design and development of effective and safe next generation agro-chemical products. 2) Evofuel – focused on the development and commercialization of castor seeds. 3) Biomica – focused on the discovery and development of human microbiome-based therapeutics.

The company recently released this illuminating overview of the technologies and company promise and progress